News
New UK support will see millions of children, including in Ghana, vaccinated against some of the world rsquo;s deadliest ...
The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for children aged 5 years of older with active lupus nephritis (LN) who are receiving standard therapy.
Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...
It is not clear how AS01 might help lower the risk of dementia, but Oxford University said lab studies show that the adjuvant ...
With the US stock market acting irrationally, this Fool UK writer explains why he’s focusing on defensive shares to avoid ...
Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.
Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria vaccine for children ‘RTS,S’ developed by GSK, PATH and partners, by more than ...
Bharat Biotech and GSK plc will significantly reduce the price of their malaria vaccine, Mosquirix, to under $5 per dose by ...
Benlysta is supplied as a single-dose prefilled autoinjector or prefilled syringe containing 200mg/mL of belimumab for SC use. The prefilled syringe has not been studied in pediatric patients aged ...
Respiratory syncytial virus (RSV) causes severe illness in millions of young children each year.1 Globally, it is estimated that over 100 000 children younger than 5 years die each year from RSV; 97% ...
HYDERABAD: Bharat Biotech International Limited (BBIL) and GSK plc on Wednesday announced a price reduction on the world’s first malaria vaccine, RTS.S. The vac ...
Bharat Biotech International Limited (BBIL) and GSK plc, a Global Pharma Company, today announced their commitment to Gavi, the Vaccine Alliance (Gavi), in the continued roll out of the world’s first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results